This is a clinical-stage biopharmaceutical company. The company is engaged in developing a disease-modifying approach to target underlying cause of Alzheimer’s disease.
This is a clinical-stage biopharmaceutical company. The company is engaged in developing a disease-modifying approach to target underlying cause of Alzheimer’s disease.